Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic Arthritis (PsaBio)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02627768
Recruitment Status : Completed
First Posted : December 11, 2015
Last Update Posted : June 21, 2021
Sponsor:
Information provided by (Responsible Party):
Janssen Pharmaceutica N.V., Belgium

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 31, 2020
Actual Study Completion Date : December 31, 2020